Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine Effects as Preemptive Analgesia
NCT06040060Phase 3Completed
- Sponsor
- Universitas Padjadjaran
- Start
- Dec 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Preemptive Ketamine with Placebo (2 arms). Primary endpoints: Duration of postoperative analgesia and Total need for post-operative analgesic rescue. Started Dec 2022; status: completed.
02
Drugs
ketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06040060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06040060.